Precision chemotherapy in biliary tract cancer moving from empiric intensification to biomarker-guided treatment: Editorial on “Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer”

Clinical and Molecular Hepatology 2026 Open access

Read full text
Authors: Sung Hwan Lee, Ahmed Omar Kaseb, Lee Ju-Seog
DOI: 10.3350/cmh.2026.0179
Cited by: 0

Abstract

Precision Chemotherapy in Biliary Tract Cancer moving From Empiric Intensification to Biomarker-Guided Treatment: Editorial on “Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced BTC.”

Fields of Study & Subjects

Cholangiocarcinoma and Gallbladder Cancer Studies Pediatric Hepatobiliary Diseases and Treatments Gallbladder and Bile Duct Disorders

Publication details

Journal / source
Clinical and Molecular Hepatology
Volume
32
Issue
3
Pages
1457–1460
Publication date
11 February 2026
Language
EN